Progressive pericardial effusion during chemotherapy for advanced Hodgkin lymphoma

American Journal of Hematology

Volumn 87, Issue 5, 2012, Pages 521-524

  Casey, David J ^a   Kim, Alice Y ^b   Olszewski, Adam J ^c  

^a ROYAL COLLEGE OF SURGEONS IN IRELAND   (Ireland)

^b MEMORIAL HOSPITAL OF RHODE ISLAND   (United States)

^c BROWN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; ANTINEOPLASTIC AGENT; CD15 ANTIGEN; CD30 ANTIGEN; COLCHICINE; HEMOGLOBIN; IBUPROFEN; TERBINAFINE;

ADULT; ADVANCED CANCER; APHTHOUS ULCER; ARTICLE; AVULSION INJURY; CANCER CLASSIFICATION; CANCER COMBINATION CHEMOTHERAPY; CANCER STAGING; CASE REPORT; CERVICAL LYMPH NODE; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; ELECTROCARDIOGRAM; HEMATOLOGICAL PARAMETERS; HUMAN; HUMAN TISSUE; LYMPH NODE BIOPSY; LYMPHADENOPATHY; MALE; MULTIPLE CYCLE TREATMENT; NAIL AVULSION; NAIL DISEASE; NEUTROPENIA; NODULAR SCLEROSIS HODGKIN LYMPHOMA; ONYCHOMYCOSIS; PERICARDIAL EFFUSION; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; THORAX RADIOGRAPHY; TREATMENT OUTCOME;

ANTI-INFLAMMATORY AGENTS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BLEOMYCIN; CARDIAC TAMPONADE; DACARBAZINE; DIAGNOSIS, DIFFERENTIAL; DIURETICS; DOXORUBICIN; EDEMA; ELECTROCARDIOGRAPHY; FUROSEMIDE; HODGKIN DISEASE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; NEOPLASM STAGING; PERICARDIAL EFFUSION; PERICARDITIS; POSITRON-EMISSION TOMOGRAPHY AND COMPUTED TOMOGRAPHY; SEROSITIS; VINBLASTINE;

EID: 84859924093     PISSN: 03618609     EISSN: 10968652     Source Type: Journal    
DOI: 10.1002/ajh.22239     Document Type: Article

References (25)

1. Hasenclever D, Diehl V. A prognostic score for advanced Hodgkin's disease. International Prognostic Factors Project on Advanced Hodgkin's Disease. NEngl J Med 1998; 339: 1506-1514.
2. Engert A, Diehl V, Franklin J, et al. Escalated-dose BEACOPP in the treatment of patients with advanced-stage Hodgkin's lymphoma: 10 years of follow-up of the GHSG HD9 study. J Clin Oncol 2009; 27: 4548-4554.
3. Scholz M, Engert A, Franklin J, et al. Impact of first- and second-line treatment for Hodgkin's lymphoma on the incidence of AML/MDS and NHL-Experience of the German Hodgkin's Lymphoma Study Group analyzed by a parametric model of carcinogenesis. Ann Oncol 2011; 22: 681-688.
4. Viviani S, Zinzani PL, Rambaldi A, et al. ABVD versus BEACOPP for Hodgkin's lymphoma when high-dose salvage is planned. N Engl J Med 2011; 365: 203-212.
5. Tsang TSM, Enriquez-Sarano M, Freeman WK, et al. Consecutive 1127 therapeutic echocardiographically guided pericardiocenteses: Clinical profile, practice patterns, and outcomes spanning 21 years. Mayo Clin Proc 2002; 77: 429-436.
6. Campbell PT, Trigt P Van, Wall TC, et al. Subxiphoid pericardiotomy in the diagnosis and management of large pericardial effusions associated with malignancy. Chest 1992; 101: 938-943.
7. Posner MR, Cohen GI, Skarin AT. Pericardial disease in patients with cancer. The differentiation of malignant from idiopathic and radiation-induced pericarditis. Am J Med 1981; 71: 407-413.
8. Porte HL, Janecki-Delebecq TJ, Finzi L, et al. Pericardoscopy for primary management of pericardial effusion in cancer patients. Eur J Cardiothorac Surg 1999; 16: 287-291.
9. Levy P-Y, Fournier P-E, Charrel R, et al. Molecular analysis of pericardial fluid: A 7-year experience. Eur Heart J 2006; 27: 1942-1946.
10. Sampat K, Rossi A, Garcia-Gutierrez V, et al. Characteristics of pericardial effusions in patients with leukemia. Cancer 2010; 116: 2366-2371.
11. Galper SL, Yu JB, Mauch PM, et al. Clinically significant cardiac disease in patients with Hodgkin lymphoma treated with mediastinal irradiation. Blood 2011; 117: 412-418.
12. Pilcher J, Zubair M. Hodgkin's disease and pericardial effusion. Thorax 1970; 5: 631-633.
13. Bashir H, Hudson MM, Kaste SC, et al. Pericardial involvement at diagnosis in pediatric Hodgkin lymphoma patients. Pediatr Blood Cancer 2007; 49: 666-671.
14. Diehl LF, Hopper KD, Giguere J, et al. The pattern of intrathoracic Hodgkin's disease assessed by computed tomography. J Clin Oncol 1991; 9: 438-443.
15. Shaffer K, Smith D, Kirn D, et al. Primary mediastinal large-B-cell lymphoma: Radiologic findings at presentation. AJR Am J Roentgenol 1996; 167: 425-430.
16. Lazzarino M, Orlandi E, Paulli M, et al. Primary mediastinal B-cell lymphoma with sclerosis: An aggressive tumor with distinctive clinical and pathologic features. J Clin Oncol 1993; 11: 2306-2313.
17. Savage KJ, Monti S, Kutok JL, et al. The molecular signature of mediastinal large B-cell lymphoma differs from that of other diffuse large B-cell lymphomas and shares features with classical Hodgkin lymphoma. Blood 2003; 102: 3871-3879.
18. Grant C, Dunleavy K, Eberle FC, et al. Primary mediastinal large b-cell lymphoma, classic hodgkin lymphoma presenting in the mediastinum, and mediastinal gray zone lymphoma: What is the oncologist to do? Curr Hematol Malig Rep 2011; 6: 157-163.
19. Floyd JD, Nguyen DT, Lobins RL, et al. Cardiotoxicity of cancer therapy. J Clin Oncol 2005; 23: 7685-7696.
20. Cosset JM, Henry-Amar M, Pellae-Cosset B, et al. Pericarditis and myocardial infarctions after Hodgkin's disease therapy. Int J Radiat Oncol Biol Phys 1991; 21: 447-449.
21. Lestuzzi C. Neoplastic pericardial disease: Old and current strategies for diagnosis and management. World J Cardiol 2010; 2: 270-279.
22. Mercé J, Sagristà-Sauleda J, Permanyer-Miralda G, Evangelista A, Soler-Soler J. Correlation between clinical and Doppler echocardiographic findings in patients with moderate and large pericardial effusion: Implications for the diagnosis of cardiac tamponade. Am Heart J 1999; 138: 759-764.
23. Sagristà-Sauleda J, Angel J, Sanchez A, et al. Effusive-constrictive pericarditis. N Engl J Med 2004; 350: 469-475.
24. Leibowitz D, Perlman G, Planer D, et al. Quantification of pericardial effusions by echocardiography and computed tomography. Am J Cardiol 2011; 107: 331-335.
25. Sagristà-Sauleda J, Angel J, Permanyer-Miralda G, Soler-Soler J. Long-term follow-up of idiopathic chronic pericardial effusion. N Engl J Med 1999; 341: 2054-2059.